Versor Investments’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-676,692
Closed -$67.2M 421
2019
Q3
$67.2M Buy
676,692
+176,585
+35% +$16.8M 4.57% 7
2019
Q2
$46.2M Buy
500,107
+82,831
+20% +$7.87M 3.08% 13
2019
Q1
$39.4M Buy
+417,276
New +$36.5M 3.74% 1

Other funds holding CELG

Versor Investments's CELG Position: Q4 2019 in Review

Versor Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 676,692 shares — an estimated $67.2M sold.

Versor Investments first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $67.2M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Versor Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Versor Investments sold 676,692 Celgene Corp shares in Q4 2019, an estimated $67.2M.
  • Versor Investments first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
  • Versor Investments's Celgene Corp position peaked at $67.2M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Versor Investments's 13F filing for Q4 2019, filed 10 Feb 2020.